Antioxidative enzyme activities after exposure to KP972 and cisplatin

Advances in Clinical and Experimental Medicine

Volumn 20, Issue 5, 2011, Pages 591-597

  Sawicka, Ewa ^a   Długosz, Anna ^a   Jȩdrzejczyk, Joanna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Antiradical effect; Cisplatin; Glutathione peroxidase; KP972; Superoxide dismutase

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GLUTATHIONE PEROXIDASE; KP 972; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SCREENING; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATIVE STRESS;

EID: 81855212393     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kadikoylu G, Bolaman Z, Demir S, Balkaya M, Akalin N, Enli Y: The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum Exp Tox 2004, 23, 29-34. (Pubitemid 38263155)
2. Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K: Rhandomized chase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer. Four-Arm Cooperative Study. Jpn Ann Oncol 2007, 18, 317-923.
3. Porȩba K, Wietrzyk J, Nowicka A: New derivative of pyridopyrazolopyrimidine with antiproliferative activity and methods of its detections. Pat Pol P379107, 2006.
4. Pat. USA 3, 669,950, 1972; C.A. 77, 88504n, 1972.
5. Pat. Ger. 215900, 1972; C.A. 77, 114401b, 1972.
6. Pat. Fr. 2200003, 1974; C.A. 82, 1687p, 1975.
7. Kumar V, Dority JA: Pat. USA 5488055, 1996;
8. CA. 125, 10805e, 1996.
9. Wolin RM, Afonio A, Kelly JM, Njorge F G.: Pat. USA 5595998, 1997; C.A. 126, 199793j, 1997.
10. Alberti MJ, Auten EP, Lackey KE, McDonald OB, Wood ER, Preugschat F, Cutler GJ, Kane-Carson L, Liu W, Jung DK: Discovery and in vitro evaluation of potent kinase inhibitors: Pyridol[1′,2′:1,5]pyrazolo[3,4-d] pyrimidines. Bioorg Med Chem Lett 2005, 15, 3778-3781. (Pubitemid 41038978)
11. Sawicka E, Długosz A, Porȩba K, Chowaniec A: Dissimilar effects of cisplatin and the pyridopyrazolo-pyrimidine derivative KP972 on free radicals. Adv Clin Exp Med 2009, 18, 415-424.
12. Mates JM, Sanchez-Jimenez F: Antioxidant enzymes and their implications in pathophysiologic processes. Clin Biochem 1999, 32, 595-603.
13. Woolliams JA, Wiener G, Anderson PH, MC Murray Ch: Variation in the activities of glutathione-peroxidase and superoxide-dismutase in relation to breed and the concentration of cooper in blood in various breed crosses. Res Vet Sci 1983, 34, 253-256. (Pubitemid 13070011)
14. Luyten CR, van Overveld FJ, De Backer LA, Sadowska AM, Rodrigus IE, De Hertc SG, De Backer WA: Antioxidant defense during cardiopulmonary bypass surgery. Eur J Cardio-Thorac 2005, 27, 611-616. (Pubitemid 40409732)
15. Paglia DE, Walentine WN: Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70, 158-168.
16. Christova TY, Gorneva GA, Taxitov SI, Duridanova B, Setchenska MS: Effect of cisplatin and cobalt chloride on antioxidant enzymes in the livers of Lewis lung carcinoma-bearing mice: protective role of heme oxygenase. Toxicol Lett 2003, 128, 235-242. (Pubitemid 36135926)
17. Maliakel DM, Kagiya TV, Nair CK: Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocoferol. Exp Toxicol Pathol 2008 Sep, 60, 521-527.
18. Chirino YI, Sanchez-Gonzalez, Matrinez-Martinez DJ, Cruz CM, Pedraza-Chaverri J: Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 2008, 245, 18-23.
19. Husain K, Morris C, Whitworth C, Trammell GL, Rybak LP, Somani SM: Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol Cell Biochem 1998, 178, 127-133. (Pubitemid 28121751)
20. Sergi B, Ferraresi A, Troiani D, Paludetti G, Fetoni AR: Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage. Hear Res 2003, 182, 56-64. (Pubitemid 37013284)
21. Youngke L, Cederbaum AI: Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol Sci 2005, 89, 2, 515-523.
22. Gonzalez RM, Puchades MJ, Garcia Ramon R: Effects of oxidative stress in patients with chronic renal failure. Nephrology 2006, 26, 218-225.
23. Serewko MM, Popa C, Dahler AL, Smith L, Strutton GM., Coman W, Dicker AJ, Saunders N: Alternations in gene expression and activity during squamous cell carcinoma development. Cancer Res 2002, 62, 3759-3765. (Pubitemid 34728858)